靶向IL-17通过下调β-catenin减轻缺氧诱导的肺动脉高压
该研究探讨IL-17在缺氧性肺动脉高压(HPH)中的作用。临床样本和小鼠模型显示IL-17表达升高,IL-17敲除减轻HPH而外源IL-17加重HPH;机制上IL-17通过上调Wnt3a/β-catenin/CyclinD1促进人肺动脉内皮细胞增殖、血管生成和黏附,中和抗体可减轻小鼠HPH。
要点
- IL-17在支气管扩张/COPD相关PH患者肺组织及HPH小鼠模型中表达升高。
- IL-17敲除减轻小鼠HPH,外源重组IL-17加重HPH,中和抗体减轻HPH。
- IL-17通过上调Wnt3a/β-catenin/CyclinD1促进HPAECs增殖、血管生成和黏附。
核心结论
- IL-17通过上调β-catenin表达参与HPH发病,靶向IL-17可能为HPH提供替代治疗策略。
研究设计与样本
- 获取合格患者的肺组织和血清临床样本。
- 在C57BL/6野生型(WT)和IL-17-/-小鼠中建立HPH模型,并给予外源重组小鼠IL-17(rmIL-17)或IL-17中和抗体处理。
- 采用增殖、血管生成和黏附实验分析人肺动脉内皮细胞(HPAECs)行为,并用非接触Transwell共培养模型评估细胞间相互作用。
主要发现
- IL-17在支气管扩张/COPD相关PH患者肺组织及HPH小鼠模型中表达增加。
- 与WT小鼠相比,IL-17-/-小鼠HPH减轻,而给予rmIL-17加重HPH。
- 重组人IL-17(rhIL-17)通过上调Wnt3a/β-catenin/CyclinD1通路促进HPAECs增殖、血管生成和黏附,siRNA敲低β-catenin几乎完全逆转该现象。
- IL-17在与HPAECs共培养的常氧和缺氧条件下促进人肺动脉平滑肌细胞(HPASMCs)增殖但不促进迁移,而对HPASMCs自身的增殖和迁移无直接作用。
- 用中和抗体阻断IL-17可减轻WT小鼠HPH。
临床怎么用
- IL-17/β-catenin轴可作为缺氧性肺动脉高压潜在治疗靶点,但需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The role of interleukin 17 (IL-17) in hypoxic pulmonary hypertension (HPH) remains unclear. This study is designed to explore whether IL-17 is a potential target for HPH treatment. METHODS: Clinic samples from the lung tissue and serum were obtained from qualified patients. Western blotting, immunohistochemistry and/or ELISA were used to measure the expression of relevant proteins. HPH models were established in C57BL/6 wild-type (WT) and IL-17-/- mice and were treated with exogenous recombinant mouse IL-17 (rmIL-17) or an IL-17 neutralising antibody. Assays for cell proliferation, angiogenesis and adhesion were employed to analyse the behaviours of human pulmonary arterial endothelial cells (HPAECs). A non-contact Transwell coculture model was used to evaluate intercellular interactions. RESULTS: Expression of IL-17 was increased in lung tissue of both patients with bronchiectasis/COPD-associated PH and HPH mouse model. Compared with WT mice, IL-17-/- mice had attenuated HPH, whereas administration of rmIL-17 aggravated HPH. In vitro, recombinant human IL-17 (rhIL-17) promoted proliferation, angiogenesis and adhesion in HPAECs through upregulation of Wnt3a/β-catenin/CyclinD1 pathway, and siRNA-mediated knockdown of β-catenin almost completely reversed this IL-17-mediated phenomena. IL-17 promoted the proliferation but not the migration of human pulmonary arterial smooth muscle cells (HPASMCs) cocultured with HPAECs under both normoxia and hypoxia, but IL-17 had no direct effect on proliferation and migration of HPASMCs. Blockade of IL-17 with a neutralising antibody attenuated HPH in WT mice. CONCLUSIONS: IL-17 contributes to the pathogenesis of HPH through upregulation of β-catenin expression. Targeting IL-17 might provide potential benefits for alternative therapeutic strategies for HPH.
引用
- Wang L, Liu J, Wang W, et al. Targeting IL-17 attenuates hypoxia-induced pulmonary hypertension through downregulation of β-catenin. Thorax. 2019. PMID: 30777899. doi:10.1136/thoraxjnl-2018-211846
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。